Early prediction of success or failure using second generation tyrosine kinase inhibitors for chronic myeloid leukemia.
Milojkovic D, Nicholson E, Apperley JF, Holyoake TL, Shepherd P, Drummond MW, Szydlo R, Bua M, Foroni L, Reid A, Khorashad JS, de Lavallade H, Rezvani K, Paliompeis C, Goldman JM, Marin D.
Haematologica. 2009 Oct 14. [Epub ahead of print]PMID: 19833633 [PubMed - as supplied by publisher]Related articlesFree article